Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
145 studies found for:    "Rothmund-Thomson Syndrome"
Show Display Options
RSS Create an RSS feed from your search for:
"Rothmund-Thomson Syndrome"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Enrolling by invitation Calcium Absorption in Patients With Rothmund-Thomson Syndrome
Condition: Rothmund-Thomson Syndrome
Intervention:
2 Terminated Peripheral Blood Biomarkers in Idiopathic Interstitial Pneumonias
Condition: Idiopathic Interstitial Pneumonias
Intervention:
3 Recruiting Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)
Condition: Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary
Interventions: Drug: Adempas, Riociguat (BAY63-2521);   Device: Placebo
4 Recruiting A Linkage and Association Study in Pulmonary Fibrosis
Conditions: Idiopathic Pulmonary Fibrosis;   Familial Pulmonary Fibrosis;   Idiopathic Interstitial Pneumonia;   Familial Interstitial Pneumonia
Intervention:
5 Recruiting Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: FG-3019;   Drug: Placebo
6 Completed
Has Results
Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis
Conditions: Alveolitis, Fibrosing;   Fibrosis, Pulmonary;   Hypertension, Pulmonary
Intervention: Drug: sildenafil
7 Unknown  Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation
Conditions: Emphysema;   Alveolitis, Fibrosing;   Cystic Fibrosis;   Bronchiectasis;   Lung Diseases
Intervention: Procedure: Pulmonary rehabilitation programme
8 Unknown  Race, Ethnicity, and Diffuse Parenchymal Lung Disease
Conditions: Idiopathic Pulmonary Fibrosis;   Interstitial Lung Disease;   Diffuse Parenchymal Lung Disease
Intervention:
9 Recruiting Investigating Significant Health Trends in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
10 Recruiting Study in Subjects With PAH and PH Secondary to IPF Using Inhaled NITROsyl
Conditions: Pulmonary Arterial Hypertension;   Idiopathic Pulmonary Fibrosis
Intervention: Drug: Inhaled Nitric Oxide
11 Completed
Has Results
Safety and PK Study of BIBF 1120 in Japanese Patients With IPF
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Placebo;   Drug: BIBF 1120
12 Recruiting The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease
Conditions: Interstitial Lung Disease;   Idiopathic Pulmonary Fibrosis;   Connective Tissue Disease
Intervention:
13 Completed Gleevec Idiopathic Pulmonary Fibrosis (IPF) Study
Conditions: Idiopathic Pulmonary Fibrosis;   Lung Disease;   Pulmonary Fibrosis
Intervention: Drug: Imatinib Mesylate (Gleevec)
14 Active, not recruiting Roll Over Study From 1199.30 BIBF 1120 in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Pulmonary Fibrosis
Intervention: Drug: BIBF 1120
15 Unknown  Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study
Conditions: Pulmonary Hypertension;   Interstitial Lung Disease;   Idiopathic Pulmonary Fibrosis;   Nonspecific Interstitial Pneumonia
Interventions: Drug: Bosentan;   Drug: Placebo
16 Unknown  Pomalidomide for Cough in Patients With Idiopathic Pulmonary Fibrosis
Condition: Pulmonary Fibrosis
Intervention: Drug: pomalidomide (CC-4047
17 Unknown  Study of Default Options in Advance Directives
Conditions: COPD;   Severe or Very Severe Airflow Obstruction and/or Receiving or Eligible to Receive Long-term Oxygen Therapy;   Idiopathic Pulmonary Fibrosis;   Other Interstitial Lung Disease Without Curative Therapy;   Congestive Heart Failure;   NYHA Class IV or NYHA Class III Plus 1 Hospitalization in the Past Year;   Malignancy;   Any Stage 3B or 4 Solid Tumor
Interventions: Other: Comfort Default AD forms;   Other: Life Extension Default AD forms;   Other: Standard Default AD forms
18 Recruiting Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
19 Recruiting A Phase 2 Study to See if Simtuzumab (GS-6624) is Safe and Works in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Simtuzumab (GS-6624);   Drug: Placebo to match simtuzumab
20 Completed Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: Pulmonary rehabilitation

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years